Chong Yang

Mr Chong Yang has served as Vice President of Commercial Development, Greater China since July, 2018. Formerly, Mr Yang held various sales and marketing leadership roles with increasing responsibilities in multinational pharmaceutical companies including Roche Oncology, Bayer Oncology, and Novartis Oncology. He brings more than 17 years of commercial experience and has extensive expertise in promoting and launching products including GLIVEC, NEXAVAR, AVASTIN, and RITUXAN in the China market.

Mr Yang earned his Master of Medicine degree from Nanjing University, China, and served as a Surgical Resident at Zhongda Hospital at Southeast University, China.